Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Immunizations in Patients with B-Cell Malignancies

Authors

Mukul Singal, Rochester Regional HealthFollow
Sanjana K. Kashinath, Rochester Regional HealthFollow
S. Shahzad Mustafa, Rochester Regional HealthFollow
Edward E. Walsh, Rochester Regional HealthFollow
Karthik Vadamalai, Mercy Hospital
Saad Jamshed, Rochester Regional HealthFollow

Department

Oncology and Hematology

Document Type

Conference Proceeding

Publication Title

Blood

Conference Name

ASH Annual Meeting

Conference Date

2021-11-05

First Page

4681

DOI

10.1182/blood-2021-153420

Volume

138

Issue

Supplement 1

Publication Date

11-23-2021

Comments

642.Chronic Lymphocytic Leukemia: Clinical and Epidemiological

Recommended Citation

Singal, M., Kashinath, S. K., Mustafa, S. S., Walsh, E. E., Vadamalai, K., & Jamshed, S. (2021). Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Immunizations in Patients with B-Cell Malignancies. Blood, 138 (Supplement 1), 4681. https://doi.org/10.1182/blood-2021-153420